FEDERATED HERMES, INC. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$19,655
-97.5%
1,095
-97.2%
0.00%
-100.0%
Q2 2023$799,564
+884.4%
39,368
+784.1%
0.00%
Q1 2023$81,223
+74.6%
4,453
+97.9%
0.00%
Q4 2022$46,530
-16.9%
2,250
+5.9%
0.00%
Q3 2022$56,000
-49.5%
2,124
-40.0%
0.00%
Q1 2022$111,000
-79.9%
3,541
-74.1%
0.00%
-100.0%
Q4 2021$553,000
+189.5%
13,678
+149.9%
0.00%
Q3 2021$191,000
+2628.6%
5,473
+2037.9%
0.00%
Q2 2021$7,000
-99.9%
256
-99.9%
0.00%
-100.0%
Q1 2021$5,318,000
+40807.7%
189,393
+36890.8%
0.01%
Q4 2020$13,000
-99.4%
512
-99.6%
0.00%
-100.0%
Q3 2020$2,010,000
+55.6%
117,285
+124.6%
0.01%
+66.7%
Q2 2020$1,292,000
-4.4%
52,225
-46.4%
0.00%
-25.0%
Q1 2020$1,352,000
+2080.6%
97,407
+1497.4%
0.00%
Q4 2019$62,000
+5.1%
6,098
-6.3%
0.00%
Q3 2019$59,000
+11.3%
6,505
-1.2%
0.00%
Q2 2019$53,000
-26.4%
6,587
+14.6%
0.00%
Q1 2019$72,000
+80.0%
5,747
+54.9%
0.00%
Q4 2018$40,000
-27.3%
3,709
-5.9%
0.00%
Q3 2018$55,0003,9410.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders